Prof. Dr. Martin Früh
Stv. Chefarzt
Leitung Fachbereich Onkologie
Medizinische Onkologie und Hämatologie · Dept. I
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma (MPM) with or without hemithoracic radiotherapy. A randomized multicenter phase II trial
31.05.2005The primary objectives of this trial are to evaluate the short-term outcomes and feasibility of neoadjuvant chemotherapy and extrapleural pneumonectomy in Part 1, and long-term outcomes and feasibility of hemithoracic radiotherapy in patients with R0...
Klinische Forschung - 31.05.2005 - 31.03.2012
Automatisch geschlossen
Projektleitung: Früh Martin
Mitarbeiter/innen: Neff Claudia
Preoperative chemoradiotherapy vs. chemotherapy alone in non-small cell lung cancer (NSCLC) patients with mediastinal lymph node metastases (stage IIIA, N2): A randomized prospective phase III trial
17.08.2001The main objective of this trial is to compare feasibility and efficacy of sequential neoadjuvant chemoradiotherapy with 44 Gy concomitant boost to neoadjuvant chemotherapy alone. Secondary objectives are to assess the value of PET in predicting path...
Klinische Forschung - 17.08.2001 - 17.08.2011
Automatisch geschlossen
Projektleitung: Früh Martin
Mitarbeiter/innen: Pfister Bogumila